3 Min Read
* Eggo waffles tested positive for Listeria in Aug. 2009
* FDA in Oct 2009 found Listeria in Atlanta plant
* Agency also found sanitation violations
* Kellogg says it has fully addressed matters raised (Adds Kellogg response; updates shares)
LOS ANGELES, Feb 16 (Reuters) - U.S. food safety regulators on Tuesday made public a January warning letter to Eggo waffle maker Kellogg Co (K.N) in which they said the company had not gone far enough to address food safety violations at its Atlanta frozen food plant.
An October 2009 Atlanta plant inspection found bacterial contamination and sanitation violations such as improper handling of trash and food, and insufficiently sanitized equipment, the FDA said.
The FDA's letter, dated Jan. 27, comes after the Georgia Department of Agriculture found Listeria bacteria in Eggo Buttermilk Waffles on Aug. 31.
Kellogg's plant had "significant deviations" from the manufacturing practices for food manufacturers and Kellogg's response so far had not addressed the violations, the agency wrote.
Kellogg said on Tuesday it has fully addressed all of the violations and that its response to the FDA letter would be filed shortly.
FDA inspectors found Listeria on five swabs from around the Atlanta plant. One of those positive swabs came from the wheels of a forklift used in the plant.
Listeria is a bacteria that can contaminate food and cause a mild illness or a severe, sometimes life-threatening, illness called invasive listeriosis.
The FDA said the company listed a number of corrective actions in its Nov. 18 updated response to the agency, but said Kellogg needed to go further.
FDA said it is "essential" for Kellogg to identify all of the areas in its facility were Listeria can grow and survive and to take the actions necessary to control the organism. The regulator also recommended that Kellogg start a pathogen monitoring program.
Kellogg said the inspections were conducted after the plant was closed for enhanced cleaning and repairs from a flood that affected production at the plant.
The company said it worked with FDA and the Georgia Department of Agriculture prior to opening the plant and that it completed comprehensive testing and monitoring.
"We have made a variety of enhancements in our facility, and have fully addressed all of the observations in the letter," Kellogg spokesman Kris Charles said in an email.
Shares in Kellogg were up 18 cents to $52.52 on the New York Stock Exchange. (Reporting by Lisa Baertlein; Additional reporting by Susan Heavey in Washington; Editing by Gerald E. McCormick and Tim Dobbyn)